Immix Biopharma, Inc. IMMX Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s compensation and benefits?
- Immix Biopharma, Inc. (IMMX) reported compensation and benefits of $880.67K in Q1 2026.
- How has Immix Biopharma, Inc.'s compensation and benefits changed year-over-year?
- Immix Biopharma, Inc.'s compensation and benefits increased by 20.3% year-over-year, from $731.79K to $880.67K.
- What is the long-term trend for Immix Biopharma, Inc.'s compensation and benefits?
- Over 2 years (2023 to 2025), Immix Biopharma, Inc.'s compensation and benefits has grown at a 27.7% compound annual growth rate (CAGR), from $577.85K to $942.16K.